Altimmune
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Altimmune and other ETFs, options, and stocks.About ALT
Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. Its lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH.
ALT Key Statistics
Stock Snapshot
The current Altimmune(ALT) stock price is $2.97, with a market capitalization of 576.75M. The stock trades at a price-to-earnings (P/E) ratio of -3.75.
As of 2026-09-29, Altimmune(ALT) stock has fluctuated between $2.92 and $3.02. The current price stands at $2.97, placing the stock +1.5% above today's low and -1.8% off the high.
Altimmune(ALT) shares are trading with a volume of 2.06M, against a daily average of 4.33M.
During the past year, Altimmune(ALT) stock moved between $2.56 at its lowest and $6.44 at its peak.
During the past year, Altimmune(ALT) stock moved between $2.56 at its lowest and $6.44 at its peak.
ALT News
...
The latest update is out from Altimmune ( (ALT) ). On September 24, 2026, Altimmune’s Board of Directors appointed Richard Menziuso as Vice President, Global C...
Altimmune (ALT) announced an update on their ongoing clinical study. Altimmune, Inc. has launched a major Phase 3 study called “A Phase 3, Multinational, Rando...
Analyst ratings
90%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.